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INTRODUCTION
During the last few decades, the survival of preterm infants
has increased dramatically (1, 2). This improvement is main-
ly due to advances in perinatal medicine and neonatal inten-
sive care. Nevertheless, the incidence of neurological impair-
ment remains high among preterm survivors. The most im-
portant neurological manifestations of brain damage in pre-
term infants are cognitive and motor disabilities. Periven-
tricular-intraventricular hemorrhage (PV-IVH) is one of the
major causes of the development of cerebral palsy and men-
tal retardation, and the incidence ranges from 15% to 40%,
depending on the center in spite of the many efforts to reduce
the incidence (3, 4). 
Identifying the risk factors and underlying mechanisms
for PV-IVH has the potential to allow for the development
of effective strategies for prevention of many neurodevelop-
mental problems of premature infants. A number of perina-
tal risk factors such as a low gestational age and birth weight,
intrauterine infection, vaginal delivery, low Apgar score, aci-
dosis and sepsis have been proposed as associated with the
pathogenesis of PV-IVH (5-7). However, only a few studies
have undertaken a multivariate analysis to identify the inde-
pendent risk factors associated with PV-IVH. Furthermore,
although prematurity is the major risk factor for PV-IVH,
many studies have not adequately controlled for birth weight
and gestational age, and the results of the studies may have
been confounded by these variables. We have therefore con-
ducted an age- and birth weight-matched control study to
adjust for these factors and to increase the sensitivity of the
detection of the potential risk factors associated with the devel-
opment of PV-IVH.
MATERIALS AND METHODS
Subjects
We conducted a retrospective case-control study from a
cohort of 1,074 preterm infants born at ≤34 weeks of ges-
tation and admitted to the Neonatal Intensive Care Units
of Seoul National University Children’s Hospital and Seoul
National University Bundang Hospital between June 2003
and December 2007. Neonates with no cranial sonographic
data obtained by three days after birth and/or neonates that
transferred from other centers after three days of age were
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excluded from the study. Of 1,044 eligible subjects, 59 infants
with PV-IVH grade 2, grade 3, and grade 4 were allocated
to the case group of infants.
To match infants without PV-IVH to the case group, ges-
tational age and birth weight were separately assigned as cri-
teria. A control group consisted of 118 infants that were select-
ed; 59 infants closely matched for gestational age and 59 infants
closely matched for birth weight to each case of PV-IVH.
Cranial ultrasounds, according to the clinical protocol of
the neonatal intensive care unit (NICU), were performed with
a 2.2-5 MHz transducer during the first three days, on the
seventh day and at the end of the third week of life. When
there was clinical suspicion of bleeding, additional ultrasound
examinations were performed. Both coronal and sagittal sec-
tions were obtained through the anterior fontanelles. The sever-
ity of PV-IVH was graded according to classification describ-
ed by Papile et al. (8). When there was more than one report,
or if there was bilateral hemorrhage, the highest grade was
selected. Other intracranial bleedings, such as a subarachnoid,
subdural and epidural hemorrhage were not concerned in
assessing PV-IVH. The first day of bleeding was defined as
the day when the hemorrhage was first identified.
Measurements
For patients that were selected for the study, the following
data were collected from both the maternal and neonatal med-
ical records. Maternal characteristics and obstetric parameters
included maternal age, parity, fertility treatment (especially
the use of in vitro fertilization), gestational age (established
or confirmed by ultrasonographic measurement of fetal biom-
etry), amount of amniotic fluid evaluated by ultrasound, pres-
ence of histological chorioamnionitis (confirmed on a patho-
logical report of the placenta), mode of delivery (Caesarian
section versus vaginal delivery), preeclampsia, premature rup-
ture of membranes (more than 18 hr before delivery), use of
tocolytic agents and use of antenatal corticosteroids (betameta-
sone or dexamethasone) in either an incomplete or a full course.
Neonatal outcome and postnatal progress factors included
birth weight, gender, Apgar score, use of an umbilical artery
catheter or umbilical vein catheter, results of cranial ultra-
sound, use of inotropic agents for hypotension, metabolic aci-
dosis and treatment of acidosis (NaHCO3), patent ductus arte-
riosus, development of respiratory distress syndrome (RDS),
mechanical ventilation, development of sepsis (clinically high-
ly suspicious or bacteriologically proven), experience of any
surgical procedure and transfusion of red blood cells or a platelet
concentrate. 
Neonatal progress factors and events developed only before
the first day of bleeding of each case of PV-IVH were collect-
ed in the case group. In control group, the same period with
the matched case was applied and neonatal factors occurred
within that period were collected. 
The use of inotropes were indicated for infants with hypo-
tension, defined as a lower mean arterial blood pressure than
the value equivalent to the gestational age in weeks or below
30 mmHg with at least one of the following clinical presen-
tations: a significantly decreased urine output, metabolic aci-
dosis and/or impairment of peripheral perfusion. Metabolic
acidosis was defined as a capillary pH value lower than 7.25
with normal pCO2 and a capillary HCO3- value lower than
20.0 mM/L. Suspicious sepsis was diagnosed when the patient
presented clinical symptoms or signs of sepsis with laborato-
ry findings suspected systemic inflammation such as leuko-
cytosis or leukopenia, thrombocytopenia and elevated C-reac-
tive protein even though negative blood cultures. Clinical
symptoms and signs included fever or hypothermia, newly
developed or increased apnea or bradycardia, hypoglycemia
or hyperglycemia. The study protocol was approved by our
institutional ethical committee. 
Statistical analysis was performed with the use of SPSS ver-
sion 16.0 (SPSS, Chicago, IL, USA). The Student’s t test was
used for comparison of the continuous variables. Pearson’s chi-
square test or Fisher’s exact test (both two-sided) were used
for comparison of the categorical variables as appropriate. Logis-
tic regression analysis was used to evaluate the independent
relationship among variables found to be significantly differ-
ent between the two groups. Only variables that reached P≤
0.10 as determined by univariate analysis were entered into
a stepwise logistic regression. The odds ratios (ORs) with a
95% confidence intervals (CIs) was calculated and a P value
<0.05 was considered as statistically significant.
Data presented as number (%).
PV-IVH, periventricular-intraventricular hemorrhage.
PV-IVH grade Total
Birth weight (g)
<1,000 1,000-1,499 1,500-1,999 ≥2,000
1 58 (58.6) 61 (84.7) 66 (93.0) 46 (95.8) 231 (79.7)
2 12 (12.1) 5 (6.9) 2 (2.8) 1 (2.1) 20 (6.9)
3 10 (10.1) 3 (4.2) 1 (1.4) 0 (0) 14 (4.8)
4 19 (19.2) 3 (4.2) 2 (2.8) 1 (2.1) 25 (8.6)
Total 99 72 71 48 290
Table 1. The incidence and severity of PV-IVH according to birth weight420 J.Y. Lee, H.S. Kim, E. Jung, et al.
RESULTS
Between June 2003 and December 2007, 1,074 infants
born at ≤34 weeks of gestation were admitted to the NICUs
of Seoul National University Children’s Hospital and Seoul
National University Bundang Hospital. Excluded patients
included 30 infants with no cranial ultrasound data obtained
by three days after birth and/or patients transferred from other
centers after three days of age. Of the 1,044 eligible subjects,
PV-IVH was diagnosed in 290 cases (27.8%); 231 cases (79.7
%) with grade 1, 20 cases (6.9%) with grade 2, 14 cases (4.8
%) with grade 3, and 25 cases (8.6%) with grade 4. The inci-
dence of PV-IVH and its severity as a function of birth weight
and gestational age are shown in Tables 1, 2.
The case group consisted of 59 infants with PV-IVH grade
2, grade 3, and grade 4. The mean gestational age and birth
weight of the case group infants were 26+6±3+2 weeks and
920.8±428.7 g, respectively. After three months from the
onset of bleeding, 10 out of 59 cases developed post-hemor-
rhagic hydrocephalus, with six infants requiring ventriculo-
peritoneal shunt insertion and one infant needing only tran-
sient external ventricular drainage. Nine (45%) of 20 cases
of grade 2 hemorrhage resolved and only one (4%) of 25 cases
Data presented as number (%).
PV-IVH, periventricular-intraventricular hemorrhage.
PV-IVH 
grade
Gestational age (weeks)
Total
≤27
+6 28
+0-31
+6 ≥32
+0
1 53 (57.0) 77 (85.5) 101 (94.4) 231 (79.7)
2 12 (12.9) 6 (6.7) 2 (1.9) 20 (6.9)
3 11 (11.8) 2 (2.2) 1 (0.9) 14 (4.8)
4 17 (18.3) 5 (5.6) 3 (2.8) 25 (8.6)
Total 93 90 107 290
Table 2. The incidence and severity of PV-IVH according to ges-
tational age
*One-way ANOVA analysis; 
� Explorative laparotomy or PDA ligation.
Data presented as number (%) or mean±standard deviation.
PV-IVH, periventricular-intraventricular hemorrhage; RBC, red blood cell; PROM, premature rupture of membrane.
Grade 2 (n=20) Clinical characteristics Grade 3 (n=14) Grade 4 (n=25) P value*
Neonatal characteristics
Gender (male:female) 7:13 (1:1.9) 9:5 (1:0.6) 13:12 (1:0.9) 0.227
Gestational age (weeks) 27
+3±3
+2 26
+4±3
+0 26
+5±3
+4 0.657
Birth weight (g) 958.8±116.0 938.2±395.5 880.6±378.6 0.824
Birth weight <10th percentile 5 (25.0) 0 (0) 6 (24.0) 0.122
Twin or Triple 9 (45.0) 9 (64.3) 14 (56.0) 0.525
Vaginal delivery 8 (40.0) 4 (28.6) 9 (44.0) 0.634
Mortality  4 (20.0) 4 (28.6) 13 (52.0) 0.069
1-min Apgar score 3.7±2.1 3.6±2.4 2.9±1.8 0.358
5-min Apgar score 5.6±2.1 4.9±1.9 4.5±2.3 0.275
Respiratory distress syndrome 12 (60.0) 10 (71.4) 18 (72.0) 0.656
Patent ductus arteriosus 1 (5.0) 9 (64.3) 22 (88.0) 0.042
Sepsis 6 (30.0) 3 (21.4) 14 (56.0) 0.063
Metabolic acidosis 16 (80.0) 12 (85.7) 24 (96.0) 0.244
Surgery
� 4 (20.0) 2 (14.3) 3 (12.0) 0.754
Mechanical ventilator care 16 (80.0) 13 (92.9) 25 (100) 0.056
Umbilical artery catheterization  4 (20.0) 4 (28.6) 6 (24.0) 0.845
Umbilical vein catheterization 5 (25.0) 3 (21.4) 8 (32.0) 0.750
Use of inotropes 15 (75.0) 11 (78.6) 25 (100) 0.032
RBC transfusion 13 (65.0) 11 (78.6) 18 (72.0) 0.998
RBC transfusion frequency 2.9±4.8 1.9±2.3 3.0±3.9 0.440
Platelet transfusion 5 (25.0) 6 (42.9) 14 (56.0) 0.112
Maternal characteristics
Maternal age (yr) 32.5±4.0 31.6±4.0 31.2±3.6 0.506
Multi-gravida 5 (25.0) 5 (35.7) 9 (36.0) 0.698
In-vitro fertilization 5 (25.0) 7 (50.0) 11 (44.0) 0.269
Preeclampsia 4 (20.0) 0 (0) 3 (12.0) 0.207
Chorioamnionitis 12 (60.0) 6 (42.9) 12 (48.0) 0.574
PROM (>18 hr) 5 (25.0) 3 (21.4) 11 (44.0) 0.245
Oligohydramnios 1 (5.0) 2 (14.3) 8 (32.0) 0.062
Use of tocolytics 7 (35.0) 10 (71.4) 16 (64.0) 0.061
Antenatal use of corticosteroid 12 (60.0) 9 (64.3) 16 (64.0) 0.953
Table 3. Comparison of neonatal and maternal characteristics among different PV-IVH gradesRisk Factors for PV-IVH in Premature Infants 421
of grade 4 hemorrhage resolved after three months. The mor-
tality rate of infants with grade 4 hemorrhage was 52%.
In the case group, demographic data, including gestational
age and birth weight showed no significant differences bet-
ween PV-IVH grade 2, grade 3, and grade 4. Patent ductus
arteriosus (P=0.042, ANOVA) and inotrope treatment (P=
0.032, ANOVA) were significantly different for PV-IVH
grade 2, grade 3, and grade 4 as shown in Table 3. In all in-
fants with grade 4 hemorrhage, inotropes were administered
before bleeding commenced.
The results of univariate analysis of the neonatal and mater-
nal demographic data for the case and the control groups are
shown in Table 4. There was no difference in terms of the
demographic data for gestational age, birth weight, propor-
tions of gender, percentage of small for gestational age, rate
of multiple pregnancies and the mode of delivery. The mor-
*Explorative laparotomy or PDA ligation.
Data presented as number (%) or mean±standard deviation.
RBC, red blood cell; PROM, premature rupture of membrane.
Case group
(n=59)
Control group
(n=118)
P
value
Case group
(n=59)
Control group
(n=118)
P
value
Neonatal characteristics
Gender (male:female) 29:30 (1:1) 64:54 (1:0.8) 0.670
Gestational age (weeks) 26
+6±3
+2 27
+6±2
+6 0.160
Birth weight (g) 920.8±428.7 970.8±414.0 0.455
Birth weight <10th percentile 11 (18.6) 35 (29.7) 0.115
Twin or Triple 32 (54.2) 53 (44.9) 0.242
Vaginal delivery 23 (39) 37 (31.4) 0.312
Mortality  21 (35.6) 17 (14.4) 0.001
1-min Apgar score  3.3±2.0 4.0±2.2 0.059
5-min Apgar score 5.0±2.1 6.0±1.9 0.001
Respiratory distress syndrome 40 (67.8) 61 (51.7) 0.041
Patent ductus arteriosus 42 (71.2) 68 (57.6) 0.080
Sepsis 23 (39.0) 21 (17.8) 0.002
Metabolic acidosis 52 (88.1) 52 (44.1) <0.001
Surgery* 9 (15.3) 5 (4.2) 0.010
Mechanical ventilator care 54 (91.5) 91 (77.1) 0.019
Umbilical artery catheterization  14 (23.7) 9 (7.6) 0.003
Umbilical vein catheterization 16 (27.1) 6 (5.1) <0.001
Use of inotropes 51 (86.4) 59 (50.0) <0.001
RBC transfusion 38 (64.4) 37 (31.4) <0.001
RBC transfusion frequency 2.7±3.9 1.0±2.0 0.003
Platelet transfusion 25 (42.4) 21 (17.8) <0.001
NaHCO3 bolus administration 54 (91.5) 68 (57.6) <0.001
Maternal characteristics
Maternal age (yr) 31.7±3.8 32.4±3.7 0.278
Multi-gravida 19 (32.2) 50 (42.4) 0.191
In vitro fertilization 23 (39.0) 43 (36.4) 0.742
Preeclampsia 7 (11.9) 32 (27.1) 0.021
Chorioamnionitis 30 (50.8) 49 (41.5) 0.240
PROM (>18 hr) 19 (32.2) 41 (34.7) 0.736
Oligohydramnios 11 (18.6) 23 (19.5) 0.893
Use of tocolytics 33 (55.9) 66 (55.9) 1.000
Antenatal use of corticosteroid 37 (62.7) 96 (81.4) 0.007
Table 4. Univariate analysis of neonatal and maternal characteristics of the case and control groups
Data presented as number (%) or mean±standard deviation.
RBC, red blood cell; CI, confidence interval.
Case (n=59) Control (n=118) Odds ratio 95% CI P value
Neonatal characteristics
1-min Apgar score 3.3±2.0 4.0±2.2 0.419 0.86 0.61-1.23
5-min Apgar score 5.0±2.1 6.0±1.9 0.568 1.11 0.77-1.60
Respiratory distress syndrome 40 (67.8) 61 (51.7) 0.370 1.63 0.56-4.74
Patent ductus arteriosus 42 (71.2) 68 (57.6) 0.357 1.57 0.60-4.09
Sepsis 23 (39.0) 21 (17.8) 0.728 1.19 0.44-3.22
Metabolic acidosis 52 (88.1) 52 (44.1) 0.038 6.94 1.12-43.23
Mechanical ventilator care 54 (91.5) 91 (77.1) 0.256 0.37 0.07-2.06
Umbilical artery catheterization  14 (23.7) 9 (7.6) 0.550 1.50 0.40-5.64
Umbilical vein catheterization 16 (27.1) 6 (5.1) 0.099 3.28 0.80-13.44
Use of inotropes 51 (86.4) 59 (50.0) 0.027 3.70 1.16-11.84
RBC transfusion 38 (64.4) 37 (31.4) 0.546 1.41 0.46-4.34
RBC transfusion frequency 2.7±3.9 1.0±2.0 0.881 0.99 0.82-1.19
Platelet transfusion 25 (42.4) 21 (17.8) 0.520 1.40 0.50-3.92
NaHCO3 bolus administration 54 (91.5) 68 (57.6) 0.882 0.86 0.11-6.46
Maternal characteristics
Preeclampsia 7 (11.9) 32 (27.1) 0.067 0.33 0.10-1.08
Antenatal use of corticosteroids 37 (62.7) 96 (81.4) 0.032 0.36 0.14-0.92
Table 5. Multivariate logistic regression analysis of neonatal and maternal characteristics of the case and control groups 
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tality rate was significantly high in the case group, 35.6%
compared to the 4.4% in the control group (P<0.001, c2-
test). Many clinical factors were significantly higher in the
case group than in the control group. The factors included
the use of mechanical ventilation, the use of umbilical artery
catheterization, the use of umbilical vein catheterization, res-
piratory distress syndrome, use of inotropes, surgery, sepsis,
red blood cell transfusion and frequency, platelet transfusion,
metabolic acidosis and treatment for acidosis by NaHCO3
administration. Negative associations were observed for the
5-min Apgar score (5.0±2.1 vs. 6.0±1.9 min; P=0.001,
c2-test), maternal preeclampsia (11.9% vs. 27.1%; P=0.021,
c2-test) and antenatal use of corticosteroids (62.7% vs. 81.4%;
P=0.007, c2-test) for the case group and control group, respec-
tively.
The multivariate logistic regression analysis showed that
metabolic acidosis (OR: 6.94; 95% CI: 1.12-43.23) and the
use of inotropes (OR: 3.70; 95% CI: 1.16-11.84) were asso-
ciated with an increased risk of PV-IVH. Maternal use of ante-
natal corticosteroids decreased the risk of PV-IVH (OR: 0.36;
95% CI: 0.14-0.92). The use of stepwise logistic regression
analysis demonstrated that the use of an umbilical vein catheter
was likely to increase the risk of PV-IVH (OR: 3.28; 95%
CI: 0.8-13.44), as shown in Table 5.
DISCUSSION
The main goal of this study was to determine the perina-
tal risk factors associated with the development of PV-IVH.
As a low birth weight and low gestational age are unquestion-
able major risk factors for PV-IVH, we performed a case-con-
trol study matching birth weight and gestational age.
We excluded grade 1 hemorrhage for the case group pati-
ents because in general, infants with a grade 1 hemorrhages
have been shown to have similar outcomes to infants that do
not develop a PV-IVH (9). Therefore, we allocated only infants
with grade 2, grade 3, and grade 4 hemorrhages to the case
group for comparison with non-hemorrhage infants.
PV-IVH is caused by bleeding from the primitive germinal
matrix, which gradually involutes with advancing gestation
(9, 10). Blood vessels in the germinal matrix next to the ven-
tricles are very fragile and vulnerable to fluctuations in blood
flow, which can cause the vessels to rupture and bleed (11). A
number of risk factors have been proposed for the development
of PV-IVH; the factors include gender (3), Apgar score (3, 5,
12, 13), premature rupture of membranes (14), intrauterine
infection (12), vaginal delivery (5, 6), in vitro fertilization (15),
mechanical ventilation (6, 16) with recurrent endotracheal
suctioning (17), a large patent ductus arteriosus (18), devel-
opment of the respiratory distress syndrome (6, 13) or sepsis
(6, 15), transfusion of blood products (15), metabolic acido-
sis (12) and rapid bicarbonate infusion (13). Maternal pree-
clampsia or gestational hypertension has been associated with
a lower rate of PV-IVH (6, 19). To reduce the incidence of
PV-IVH, several pharmacological interventions have been
proposed, including the administration of antenatal steroids,
prenatal tocolytic therapy (16), postnatal administration of
low-dose indomethacin and surfactants (20-22).
We found no significant difference in this study for the fol-
lowing risk factors: gender, restricted intrauterine growth,
multiple pregnancies, mode of delivery, premature rupture of
membrane, in vitro fertilization, tocolysis, oligohydramnios
and chrioamnionitis. However a significant association was
found for metabolic acidosis and the use of inotropes based on
multivariate logistic regression analysis. Even though found
as statistically not significant based on logistic regression, red
blood cell transfusion, platelet concentrate transfusion and
bolus NaHCO3 parental administration were all significant-
ly high in the case group based on the use of univariate analysis
(64.4% vs. 31.4%; P≤0.001, 42.2% vs. 17.8%; P≤0.001
and 91.5% vs. 57.6%; P≤0.001, c2-test, respectively for the
case group and the control group). The use of an umbilical
artery and vein catheters were likely to contribute to an in-
creased risk for PV-IVH (23.7% vs. 7.6%; P=0.003 and 27.1%
vs. 5.1%; P≤0.001, respectively, for the case group and the
control group).
These results contribute to the understanding of the patho-
genesis of PV-IVH. Metabolic acidosis, use of inotropes, trans-
fusion of blood products and sodium bicarbonate bolus infu-
sions are all related as influencing a change of cerebral circula-
tion (23). Furthermore, the withdrawal and infusion of blood
via umbilical catheters can cause a significant rapid change
of cerebral blood flow of preterm infants (24). Perlman et al.
have demonstrated that the alteration from auto-regulation
to a pressure-passive circulatory pattern appears to be an im-
portant step in the development of PV-IVH (23). When a
pressure-passive circulatory pattern is challenged with fluc-
tuations of cerebral blood flow and pressure, hemorrhage can
occur in the immature germinal matrix (23-25). In animal
models, hypoxia-ischemia compromises cerebral auto-regu-
lation of premature infants (26). Specific metabolic derange-
ments (e.g., hypocarbia, hypercarbia, hypoxemia and acido-
sis) also can disrupt the auto-regulatory abilities in preterm
infants (27). Rapid alteration in the acid-base status as well
as hypoxia can overwhelm the ability of the neonate to pro-
tect cerebral circulation and can result in PV-IVH.
In this study, we evaluated the use of inotropes for involve-
ment in circulatory instability. As demonstrated in the new-
born beagle puppy model, cerebral hyperperfusion following
cerebral hypoperfusion and ischemia is fundamental to the
hemodynamic basis of PV-IVH (26). In the absence of auto-
regulation, the systemic blood pressure becomes the prima-
ry determinant of cerebral blood flow and pressure, which is
a pressure-passive circulatory situation. Rapid volume expan-
sion with blood products or hypertonic solutions and exces-
sive use of inotropes for the correction of hypotension results
in a rapid increase of cerebral blood flow and can cause injuryRisk Factors for PV-IVH in Premature Infants 423
to fragile germinal matrix capillaries (5, 23, 28, 29). More
research remains to be performed to determine proper criteria
or detailed methods for neonatal intensive care that minimize
the rapid alteration of hemodynamics of preterm infants.
In the analysis of the prenatal factors, maternal preeclamp-
sia and the use of antenatal corticosteroids were significantly
low in the case group as compared to the control group. When
analyzed with the use of multivariate logistic regression, only
corticosteroid use was associated with a decreased risk of PV-
IVH. Increasing evidence suggests that the incidence of PV-
IVH is lower in infants born to mothers with pregnancy-in-
duced hypertension. The mechanism that accounts for this
reduction remains unclear, but may be related to medication
used to treat the mother (e.g., magnesium sulfate) or to the
obstetrical management (19). Consistent with the results of
this study, antenatal steroid treatment has been reported as
conferring protection against the development of PV-IVH
(30). The mechanisms by which corticosteroids decrease the
risk of hemorrhage are unclear, but they appear to be inde-
pendent of enhanced pulmonary maturation. The postulat-
ed effects include an anti-angiogenic effect with inhibition
of microvessel morphogenesis in the germinal matrix capil-
lary network and stabilization of the microvasculature of the
developing germinal matrix (30).
In contrast to previous reports which demonstrated causes
of PV-IVH irrelevant to each other, the results of this study
exhibit factors related to hemodynamic changes as risk fac-
tors of PV-IVH. Many factors which are not statistically sig-
nificant in this study could be related to influence circulato-
ry blood flow. However metabolic acidosis and its treatment
with bolus NaHCO3, use of inotropes for hypotension, use
of umbilical catheters and transfusion of blood products are
all related to circulatory volume changes directly. These find-
ings suggest that hemodynamic changes of systemic and cere-
bral circulation are important for the development of PV-IVH
in preterm newborns. As the survival rate of extremely preterm
infants has remarkably increased recently, more delicate hemo-
dynamic balancing has come to be more essential than any
other perinatal factors that have been proposed in previous
studies for the prevention of PV-IVH.
We were unable to differentiate early and late PV-IVH in
this study. In general, it is likely that early PV-IVH has risk
factors that relate to the intrapartum period, whereas late PV-
IVH that occurs after a few days of life may well relate to early
postnatal hemodynamic factors. However, there is no estab-
lished definition to distinguish between early and late PV-
IVH (5, 12). An additional investigation is needed to deter-
mine the timing of the cerebral injury in premature infants
and to define an accepted definition distinguishing early and
late PV-IVH. Furthermore, future research should be direct-
ed at identifying the distinct hemodynamic risk factors for
early and late of PV-IVH in premature infants.
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